Europe's news in English

COPY LINK

HEALTH

US attempts to poach German scientists to develop exclusive coronavirus vaccine

The United States and Germany are vying to produce an exclusive vaccine against the coronavirus which is being developed in a German laboratory, Die Welt daily reported Saturday

Published: 15 March 2020 14:09 CET

US attempts to poach German scientists to develop exclusive coronavirus vaccine

Photo: DPA

According to the paper, US President Donald Trump is trying to poach German scientists working on an experimental vaccine against a global health threat that has now killed some 5,500 people with a view to having an exclusive licence rolled out in the United States.

German media reports US authorities are trying to outbid German authorities by offering higher sums of money.

Coronavirus: These are the measures in Germany you need to know about

Such a vaccine would be “only for the United States,” a source close to the German government told Die Welt, though Berlin would reportedly is looking to make offers of its own to biotech firm CureVac, based in the German state of Thuringia.

The company, founded in 2000, has other sites in Frankfurt and Boston. The firm markets itself as specialising in “development of treatments against cancer, antibody-based therapies, treatment of rare illnesses and prophylactic vaccines.”

The lab is currently working in tandem with the Paul-Ehrlich Institute, linked to the German ministry of health. It specialises in vaccine research.

“The German government is very interested in having the development of vaccines and active substances against the novel coronavirus undertaken in Germany and Europe,” a health ministry spokesman told Die Welt, adding that the government was in “intensive” talks with CureVac.

As CureVac CEO, Daniel Menichella found himself invited on March 2 to the White House to meet with Trump, his vice-president Mike Pence and representatives of pharma companies working on how to respond to the pandemic, the company revealed on its website without indicating if financial offers had been put on the table.

“We are very confident that we will be able to develop a potent vaccine candidate within a few months,” CureVac quoted Menichella — who has since given way to founder and incoming CEO Ingmar Hoerr — as saying following his Washington visit.

Member comments

Log in here to leave a comment.

Become a Member to leave a comment.

Could there be a new wave of Covid-19 in Germany this autumn?

More people donning face masks in supermarkets, friends cancelling plans last minute due to getting sick with Covid-19. We might have seen some of those familiar reminders recently that the coronavirus is still around, but could there really be a resurgence of the virus like we experienced during the pandemic years?

According to virologists, the answer seems to be ‘maybe’: since July, the number of people newly infected with Covid-19 has been slowly rising from a very low level.

According to the Robert Koch Institute (RKI), nine people per 100,000 inhabitants became newly infected in Germany last week. A year ago, there were only around 270 reported cases.

Various Corona variants are currently on the loose in the country. According to the RKI, the EG.5 (also called Eris) and XBB.1.16 lines were each detected in the week ending September 3rd with a share of just under 23 percent.

The highly mutated variant BA.2.86 (Pirola), which is currently under observation by the World Health Organisation (WHO), also arrived in the country this week, according to RKI.

High number of unreported case

The RKI epidemiologists also warned about a high number of unreported cases since hardly any testing is done. They pointed out that almost half of all registered sewage treatment plants report an increasing viral load in wastewater tests.

The number of hospital admissions has also increased slightly, but are still a far cry from the occupation rate amid the pandemic. Last week it was two per 100,000 inhabitants. In the intensive care units, only 1.2 percent of all beds are occupied by Covid-19 patients.

Still, a good three-quarters (76.4 percent) of people in Germany have been vaccinated at least twice and thus have basic immunity, reported RKI.

Since Monday, doctors’ offices have been vaccinating with the adapted vaccine from Biontech/Pfizer, available to anyone over 12 years old, with a vaccine for small children set to be released the following week and one for those between 5 and 11 to come out October 2nd.

But Health Minister Karl Lauterbach has so far only recommended that people over 60 and those with pre-existing conditions get vaccinated.

READ ALSO: EXPLAINED: Who should get a Covid jab this autumn in Germany?

“The pandemic is over, the virus remains,” he said. “We cannot predict the course of coming waves of corona, but it is clear that older people and people with pre-existing conditions remain at higher risk of becoming severely ill from Covid-19”

The RKI also recommended that people with a cold voluntarily wear a mask. Anyone exhibiting cough, cold, sore throat or other symptoms of a respiratory illness should voluntarily stay at home for three to five days and take regular corona self-tests.

However, further measures such as contact restrictions are not necessary, he said.

One of many diseases

As of this autumn, Covid-19 could be one of many respiratory diseases. As with influenza, there are no longer absolute infection figures for coronavirus.

Saarbrücken pharmacist Thorsten Lehr told German broadcaster ZDF that self-protection through vaccinations, wearing a mask and getting tested when symptoms appear are prerequisites for surviving the Covid autumn well.

Only a new, more aggressive mutation could completely turn the game around, he added.

On April 7th of this year, Germany removed the last of its over two-year long coronavirus restrictions, including mask-wearing in some public places.

READ ALSO: German doctors recommend Covid-19 self-tests amid new variant

Url copied to clipboard!